1. Implications of switching away from injectable hormonal contraceptives on the HIV epidemic
- Author
-
Benjamin Armbruster and Kezban Yagci Sokat
- Subjects
Economics and Econometrics ,business.industry ,Transmission (medicine) ,Strategy and Management ,Geography, Planning and Development ,Hiv epidemic ,Human immunodeficiency virus (HIV) ,virus diseases ,Management Science and Operations Research ,medicine.disease_cause ,Hiv prevalence ,Contraceptive use ,Hormonal contraception ,medicine ,Hiv status ,Statistics, Probability and Uncertainty ,Hiv transmission ,business ,Demography - Abstract
A recent study showed that progestogen-only injectable hormonal contraception (POIHC) doubles the risk of HIV transmission. This may affect contraceptive use and HIV-related outcomes, if women switch away from POIHC. A deterministic compartmental model of individuals aged 15–49 distinguishing gender and HIV status was used to simulate various contraceptive use scenarios. We specifically tracked HIV prevalence, new infections, HIV-related deaths, vertical transmission, and births over a 15-year period for five African countries. Stopping POIHC use will result in a large increase in births and vertical transmission. Switching from POIHC to other contraceptives limits these increases while still improving HIV outcomes.
- Published
- 2015
- Full Text
- View/download PDF